Current methods to generate cells from human-induced pluripotent stem cells (iPSCs) lack reproducibility and scalability. This raises challenges for disease research, drug discovery and cell therapy development due to unreliable data and long experimental timelines. However, there is a new technology on the block, enabling reproducible, consistent and scalable production of physiologically relevant human cells giving scientists more confidence in their experiments!
- Higher culture purity with defined cell identity
- Unlimited and consistent manufacture of any human cell
- Short culture time